MedPath

Regional Anaesthesia for Inguinal Hernia Repair

Completed
Conditions
Disease of intestine, unspecified,
Registration Number
CTRI/2015/08/006104
Lead Sponsor
Lady Hardinge Medical Collee
Brief Summary

The aim of study was to evaluate and compare the duration of postoperative analgesia, determine the time to reach the discharge criteria, asses the incidence of side effects such as nausea, vomiting, urinary retention and observe the hemodynamic parameter during intra-operative period.  In our study we found prolonged postoperative analgesia, shorter time to reach the discharge criteria,  lesser incidence of side effects and better hemodynamic stability in paravertebral group as compared to spinal anaesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
60
Inclusion Criteria

Healthy patients ASA grade I & II Male Unilateral inguinal Hernia ( Indirect or direct with fully reducible).

Exclusion Criteria

Patients having known cardivascular, respiartory, renal, hepatic or metabolic disease, active gastriintestinal reflux, mental dysfunction, morbid obesity, history of substance abuse, chronic analgesic use and history of analgesic use and history of allergy to local anaesthetics and infections at the block site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The duration of post-operative analgesia was higher in paravertebral (PVB) group as compared to the spinal anaesthesia (SA). Also shorter time taken to reach the discharge criteria for home readiness in PVB group as compared to SA group.Both assessed postoperatively at 2, 4, 6, 12 and 24 hrs
Secondary Outcome Measures
NameTimeMethod
The incidence of side effects such as PONV, headache and urinary cathertisation were higher in SA group as to PVB. Significant decrease in blood pressure seen in SA as compared to the PVB block . No significant changes seen in heart rate and oxygen saturation.Incidence of side effect observe post operatively for 24 hrs.

Trial Locations

Locations (1)

Lady Hardinge Medical college

🇮🇳

Central, DELHI, India

Lady Hardinge Medical college
🇮🇳Central, DELHI, India
yudhyavir brahmchari
Principal investigator
9811140057
yudhyavir@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.